Vanguard Group Inc. Has $19.96 Million Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE)

Vanguard Group Inc. boosted its stake in shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) by 15.1% during the 4th quarter, Holdings Channel reports. The institutional investor owned 1,146,339 shares of the company’s stock after buying an additional 150,506 shares during the quarter. Vanguard Group Inc.’s holdings in Pulse Biosciences were worth $19,958,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. KLP Kapitalforvaltning AS bought a new position in Pulse Biosciences during the 4th quarter worth approximately $44,000. Farther Finance Advisors LLC raised its stake in Pulse Biosciences by 44.4% during the fourth quarter. Farther Finance Advisors LLC now owns 7,220 shares of the company’s stock worth $126,000 after buying an additional 2,220 shares during the last quarter. SG Americas Securities LLC bought a new stake in Pulse Biosciences during the fourth quarter valued at $193,000. Bender Robert & Associates acquired a new stake in Pulse Biosciences during the 4th quarter worth about $202,000. Finally, Oppenheimer & Co. Inc. acquired a new position in shares of Pulse Biosciences in the 4th quarter valued at about $311,000. Institutional investors own 76.95% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com upgraded Pulse Biosciences to a “sell” rating in a report on Monday, March 31st.

Pulse Biosciences Price Performance

NASDAQ PLSE opened at $16.89 on Thursday. Pulse Biosciences, Inc. has a 12-month low of $6.60 and a 12-month high of $25.00. The company has a fifty day simple moving average of $17.49 and a 200 day simple moving average of $17.91.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.